Therapy insight: The recognition and treatment of retinal manifestations of systemic vasculitis

Nature Clinical Practice Rheumatology

Volumn 2, Issue 8, 2006, Pages 443-451

  Aristodemou, Petros ^a   Stanford, Miles ^b,c  

^a ROYAL UNITED HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; FOLIC ACID; FOSCARNET; GANCICLOVIR; METHOTREXATE; STEROID;

ANAPHYLACTOID PURPURA; AORTA ARCH SYNDROME; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; CYTOMEGALOVIRUS; DRUG INDICATION; FLUORESCENCE ANGIOGRAPHY; FOLIC ACID DEFICIENCY; GIANT CELL ARTERITIS; GOODPASTURE SYNDROME; HERPES SIMPLEX VIRUS; HUMAN; IMMUNE DEFICIENCY; INFECTION RISK; ISCHEMIC OPTIC NEUROPATHY; MICROSCOPIC POLYANGIITIS; OPHTHALMOSCOPY; OPTIC NERVE DISEASE; PATHOPHYSIOLOGY; POLYARTERITIS NODOSA; POLYCHONDRITIS; PRIORITY JOURNAL; RETINA ARTERY OCCLUSION; RETINA DISEASE; RETINITIS; REVIEW; RHEUMATOID ARTHRITIS; SCLERODERMA; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC VASCULITIS; VARICELLA ZOSTER VIRUS; VISUAL ACUITY; WEGENER GRANULOMATOSIS;

CLINICAL TRIALS; FLUORESCEIN ANGIOGRAPHY; HUMANS; RETINA; RETINAL DISEASES; RETINAL VESSELS; VASCULITIS;

EID: 33746937877     PISSN: 17458382     EISSN: 17458390     Source Type: Journal    
DOI: 10.1038/ncprheum0268     Document Type: Review

References (50)

1. Jennette JC and Falk RJ (1997) Small vessel vasculitis. N Engl J Med 337:1512-1523
2. McLeod D (2005), Why cotton wool spots should not be regarded as retinal nerve fibre layer infarcts. Br J Ophthamol 89:229-237
3. Yanoff M and Fine BS (eds; 2002) Ocular Pathology, edn 5. Missouri: Mosby
4. Ushiyama O et al. (2000) Retinal disease in patients with systemic lupus erythematosus. Ann Rheum Dis 59: 705-708
5. Olver JM (1990) Functional anatomy of the choroidal circulation: Methyl methacrylate casting of the human choroid. Eye 4: 262-272
6. Hayreh SS et al. (1998) Ocular manifestations of giant cell arteritis. Am J Ophthalmol 125: 509-520
7. Mack HG et al. (1991) Delayed choroidal perfusion in giant cell arteritis. J Clin Neuroophthalmol 11: 221-227
8. Harman LE and Margo CE (1998) Wegener's granulomatosis. Surv Ophthalmol 42: 458-480
9. Weyand CM and Goronzy JJ (2003) Medium- and large-vessel vasculitis. N Engl J Med 349:160-169
10. Wilkinson IM and Russell RW (1972) Arteries of the head and neck in giant cell arteritis. A pathological study to show the pattern of arterial involvement. Arch Neurol 27: 378-391
11. Ghanchi FD and Dutton GN (1997) Current concepts in giant cell (temporal) arteritis. Surv Cphthalmol 42: 99-123
12. Jonasson F et al. (1979) Temporal arteritis. A 14-year epidemiological, clinical and prognostic study. Scott Med J 24:111-117
13. Hsu CT et al. (2001) Choroidal infarction, anterior ischemic optic neuropathy, and central retinal artery occlusion from polyarteritis nodosa. Retina 21: 348-351
14. Morgan CM et al. (1986) Retinal vasculitis in polyarteritis nodosa. Retina 6: 205-209
15. Mirza S et al. (1999) Central retinal artery occlusion and bilateral choroidal infarcts in Wegener's granulomatosis. Eye 13: 374-376
16. Howe L et al. (1995) Anterior ischaemic optic neuropathy in Wegener's granulomatosis. Eur J Ophthalmol 5: 277-279
17. Takanashi T et al. (2001) Orbital inflammatory pseudotumour and ischaemic vasculitis in Churg-Strauss syndrome. Ophthalmology 108: 1129-1133
18. Partal A et al. (2003) Churg-Strauss syndrome in a child: Retinal and optic nerve findings. Br J Ophthalmol 88: 971-972
19. Isaak BL et al. (1986) Ocular and systemic findings in relapsing polychondritis. Ophthalmology 93: 681-689
20. Sundaram MB and Rajput AH (1983) Nervous system complications of relapsing polychondritis. Neurology 33: 513-515
21. Gold DH et al. (1972) Ocular findings in systemic lupus erythematosus. Br J Ophthalmol 56: 800-804
22. Lanham JG et al. (1982) SLE retinopathy: Evaluation by fluorescein angiography. Ann Rheum Dis 41: 473-478
23. Jabs DA et al. (1986) Severe retinal vaso-occlusive disease in systemic lupus erythematosus. Arch Ophthalmol 104: 558-563
24. Nguyen QD et al. (2000) Choroidopathy of systemic lupus erythematosus. Lupus 9: 288-298
25. Gharbiya M et al. (2002) Indocyanine green angiographic findings in systemic lupus erythematosus. Am J Ophthalmol 134: 286-290
26. Cunningham ET et al. (1996) Central serous chorioretinopathy in patients with systemic lupus erythematosus. Ophthalmology 103: 2081-2090
27. Jabs DA et al. (1986) Optic neuropathy in systemic lupus erythematosus. Arch Ophthalmol 104: 564-568
28. Graham E et al. (1985) Cerebral and retinal vascular changes in systemic lupus erythematosus. Ophthalmology 92: 444-448
29. Ushiyama O et al. (2000) Retinal disease in patients with systemic lupus erythematosus. Ann Rheum Dis 59: 705-708
30. Montehermoso A et al. (1999) Association of antiphospholipid antibodies with retinal vascular disease in systemic lupus erythematosus. Semin Arthritis Rheum 28: 326-332
31. Tso MO and Jampol LM (1982) Pathophysiology of hypertensive retinopathy. Ophthalmology 89: 1132-1145
32. de Venecia G and Jampol LM (1984) The eye in accelerated hypertension. II. Localized serous detachments of the retina in patients. Arch Ophthalmol 102: 68-73
33. Agrawal A et al. (2003) Visual symptoms in patients on cyclophosphamide may herald sight-threatening disease. Br J Ophthalmol 87: 122-123
34. Bartelmann E et al. (2005) Cytomegalovirus retinitis in Wegener's granulornatosis: Case report and review of the literature. Acta Ophthalmol Scand 83: 258-261
35. Clare G et al. (2005) Reversible optic neuropathy associated with low-dose methotrexate therapy. J Neuroophthalmol 25: 109-112
36. Marmor MF et al. (2002) Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: A report by the American Academy of Ophthalmology. Ophthalmology 109: 1377-1382
37. Mavrikakis ι et al. (2003) The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: A reappraisal. Ophthalmology 110: 1321-1326
38. Rucker JC et al. (2004) Ischemic optic neuropathies. Curr Opin Neurol 17: 27-35
39. Haryeh SS et al. (1998) Occult giant cell arteritis: Ocular manifestations. Am J Ophthalmol 125: 521-526
40. Chun YS et al. (2001) The clinical and ocular manifestations of Takayasu arteritis. Retina 21: 132-140
41. Lewis JR et al. (1993) Pulseless (Takayasu) disease with ophthalmic manifestations. J Clin Neuroophthalmol 13: 242-249
42. Jampol LM et al. (1975) Ocular clinical findings and basement membrane changes in Goodpasture's syndrome. Am J Ophthalmol 79: 452-463
43. Rowe PA et al. (1994) Ophthalmic features of fourteen cases of Goodpasture's syndrome. Nephron 68: 52-56
44. Chen CL et al. (2000) Cerebral vasculitis in Henoch-Schönlein purpura: A case report with sequential magnetic resonance imaging changes and treated with plasmapheresis alone. Pediatr Nephrol 15: 276-278
45. Dandekar SS et al. (2004) Ocular involvement in systemic vasculitis associated with perinuclear antineutrophil cytoplasmic antibodies. Arch Ophthalmol 122: 786-787
46. Minasian M et al. (2005) Bilateral ischaernic retinal vasculopathy in scleroderma. Br J Ophthalmol 89: 1064-1065
47. Serup L et al. (1987) Fundus fluorescein angiography in generalized scleroderma. Ophthalmic Res 19: 303-308
48. Peric S et al. (2001) Anterior ischaemic optic neuropathy in patients with rheumatoid arthritis - case report. Coll Antropol 25 (Suppl): 67-70
49. Matsuo T et al. (1990) Retinal vasculitis as a complication of rheumatoid arthritis. Ophthalmologica 201: 196-200
50. Matsuo T et al. (1997) Geographic choroiditis and retinal vasculitis in rheumatoid arthritis. Jpn J Ophthalmol 42: 51-55